These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1213 related articles for article (PubMed ID: 18715834)
1. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study. Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834 [TBL] [Abstract][Full Text] [Related]
2. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases]. Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380 [TBL] [Abstract][Full Text] [Related]
3. Prognostic factors and role of salvage surgery in chemorefractory ovarian germ cell malignancies: a study in Chinese patients. Li J; Yang W; Wu X Gynecol Oncol; 2007 Jun; 105(3):769-75. PubMed ID: 17459461 [TBL] [Abstract][Full Text] [Related]
4. [BEP/VIP in children and adolescents with malignant non-testicular germ cell tumors. A comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89]. Göbel U; Calaminus G; Teske C; Bamberg M; Bökkerink JP; Haas RJ; Holschneider AM; Janka-Schaub G; Jürgens H; Mittler U Klin Padiatr; 1993; 205(4):231-40. PubMed ID: 7690864 [TBL] [Abstract][Full Text] [Related]
13. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Low JJ; Perrin LC; Crandon AJ; Hacker NF Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171 [TBL] [Abstract][Full Text] [Related]
14. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942 [TBL] [Abstract][Full Text] [Related]
15. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study. Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477 [TBL] [Abstract][Full Text] [Related]
16. Resection of thoracic and abdominal teratoma in patients after cisplatin-based chemotherapy for germ cell tumor. Late results. Loehrer PJ; Mandelbaum I; Hui S; Clark S; Einhorn LH; Williams SD; Donohue JP J Thorac Cardiovasc Surg; 1986 Oct; 92(4):676-83. PubMed ID: 3020319 [TBL] [Abstract][Full Text] [Related]
17. A phase II study of high-dose cisplatin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Culine S; Kattan J; Lhomme C; Duvillard P; Michel G; Castaigne D; Leclere J; Pico J; Droz JP Gynecol Oncol; 1994 Jul; 54(1):47-53. PubMed ID: 7517380 [TBL] [Abstract][Full Text] [Related]
18. Mixed mesodermal tumor of the ovary: analysis of prognostic factors in 31 cases. Barakat RR; Rubin SC; Wong G; Saigo PE; Markman M; Hoskins WJ Obstet Gynecol; 1992 Oct; 80(4):660-4. PubMed ID: 1328975 [TBL] [Abstract][Full Text] [Related]
19. Ovarian germ cell tumours: a 17-year study in a single unit. Panteli C; Curry J; Kiely E; Pierro A; de Coppi P; Anderson J; Sebire N; Drake D Eur J Pediatr Surg; 2009 Apr; 19(2):96-100. PubMed ID: 19360543 [TBL] [Abstract][Full Text] [Related]